However, in the subgroup of patients with suboptimally cytoreduced tumours, the PFI of patients with tumours that stained strongly for HIF-1α was significantly worse than that of patients with tumours that stained weakly or were negative for HIF-1α, and in those patients it proved to be an independent prognostic factor. The gene discussed is HIF1A; the disease is neoplasm.